Related by context. Frequent words. (Click for all words.) 66 RegeneRx Biopharmaceuticals Inc. 65 Vicor Technologies Inc. 65 OTCQX RHHBY 63 Genaera Corporation 63 NASDAQ ARIA 63 Ligand Pharmaceuticals Incorporated 63 Metabasis Therapeutics Inc. 63 Pivotal Phase III 63 Nasdaq VRTX 62 Aradigm Corporation 62 Celsion Corporation 62 Amarillo Biosciences Inc. 62 Inc. Nasdaq IMGN 62 Response Genetics Inc. 62 Aethlon Medical Inc. 61 Inc. Nasdaq EXEL 61 Guanilib 61 Hepatitis C HCV 61 Harbor BioSciences 61 AVEO Pharmaceuticals Inc. 60 AVANIR Pharmaceuticals 60 Kiadis Pharma 60 Nasdaq REGN 60 EPIX Pharmaceuticals Inc. 60 Pluristem Therapeutics Inc. 60 GlaxoSmithKline plc GSK 60 Inc. NASDAQ CLDA 60 OncoGenex Pharmaceuticals Inc. 60 Applied NeuroSolutions 60 Phase III Clinical Trial 60 anticancer compound 60 Cortex Pharmaceuticals 60 Halozyme Therapeutics 59 PEG SN# 59 Nymox Pharmaceutical Corporation 59 XTENT 59 Idera Pharmaceuticals Inc. 59 GammaCan 59 Phase Ib clinical 59 Inc. Nasdaq GNVC 59 CTI Nasdaq 59 ImmunoCellular Therapeutics 59 MacroChem 59 Panzem R 59 NASDAQ SHPGY 59 ADVENTRX Pharmaceuticals Inc. 59 ARIAD Pharmaceuticals Inc. 59 Pharmion Corporation 59 Chemokine Therapeutics 59 ZIOPHARM Oncology Inc. 59 liposomal formulation 59 Cyclacel Pharmaceuticals Inc. 59 IND submission 59 Nasdaq DNDN 59 Telavancin 59 Sunesis Pharmaceuticals 59 IMMU 58 phase IIa 58 Phase IIb trials 58 VIA Pharmaceuticals 58 Complete Response 58 Andrx Corporation 58 Hana Biosciences 58 Hybridon 58 NovaBay Pharmaceuticals 58 Bicifadine 58 Phase IIa trial 58 Idera Pharmaceuticals 58 NASDAQ BPAX 58 Nile Therapeutics 58 NASDAQ IMCL 58 Oscient Pharmaceuticals 58 VIAject 58 Icatibant 58 Mipomersen 58 IR BioSciences Holdings 58 EOquin 58 Company NASDAQ MDCO 58 Phase 2a trial 58 Phenoptin 58 Lev Pharmaceuticals 57 Compugen Ltd. 57 Response Genetics 57 pharmacokinetic PK 57 TSX TLN 57 Rosetta Genomics Ltd. 57 Inc. Nasdaq SGEN 57 Vicor Technologies 57 ImmunoGen Inc. 57 Helix BioPharma 57 phase IIb clinical 57 teduglutide 57 Dynavax Technologies Corporation 57 Progenics Pharmaceuticals 57 IMPAX Laboratories Inc. 57 NASDAQ AMAG 57 ponatinib 57 Inc Therapeutic Competitors 57 Phase 2a clinical 57 Celator 57 IDIX